Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00003498 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Non Hodgkin Lymphoma

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute